{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:37:19Z","timestamp":1771875439914,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1002\/jps.22649","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T22:38:32Z","timestamp":1306881512000},"page":"4965-4973","source":"Crossref","is-referenced-by-count":14,"title":["Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach"],"prefix":"10.1016","volume":"100","author":[{"given":"Kazuyoshi","family":"Yoshii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Mera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22649_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2982.2009.01261.x","article-title":"A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia","volume":"21","author":"Tack","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1002\/jps.22649_bb0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.110.174847","article-title":"Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: Comparison with cisapride, itopride, and mosapride","volume":"336","author":"Matsunaga","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1002\/jps.22649_bb0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0021-5198(19)41268-7","article-title":"Z-338, a novel gastroprokinetic agent stimulates gastrointestinal motor activity and improves delayed gastric emptying in the dog and rat","volume":"76","author":"Matsunaga","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1002\/jps.22649_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0404.2005.00374.x","article-title":"Myasthenia gravis: Clinical, immunological, and therapeutic advances","volume":"111","author":"Romi","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1002\/jps.22649_bb0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/aps.2009.191","article-title":"Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole","volume":"31","author":"Zheng","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"10.1002\/jps.22649_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22649_bb0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jps.2600770304","article-title":"Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues","volume":"77","author":"Kim","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22649_bb0045","first-page":"G642","article-title":"Importance of the liver in plasma clearance of hepatocyte growth factors in rats","volume":"263","author":"Liu","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1002\/jps.22649_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"Commentary: A physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.22649_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance","volume":"5","author":"Pang","year":"1977","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.22649_bb0060","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1128\/AAC.46.7.2219-2228.2002","article-title":"Physiologically based pharmacokinetic model for terbinafine in rats and humans","volume":"46","author":"Hosseini-Yeganeh","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.22649_bb0065","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jps.2600761205","article-title":"Tubulin as a major determinant of tissue distribution of vincristine","volume":"76","author":"Wierzba","year":"1987","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22649_bb0070","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1128\/MCB.21.16.5471-5477.2001","article-title":"Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene","volume":"21","author":"Jonker","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1002\/jps.22649_bb0075","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1006\/bbrc.1996.1056","article-title":"cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2","volume":"224","author":"Okuda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jps.22649_bb0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","article-title":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin","volume":"302","author":"Wang","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22649_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejphar.2004.06.040","article-title":"Drug\u2013drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338","volume":"497","author":"Furuta","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.22649_bb0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/abbi.2000.1777","article-title":"Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract","volume":"377","author":"Grams","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1002\/jps.22649_bb0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.31.3.326","article-title":"Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family","volume":"31","author":"Shelby","year":"2003","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915318323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915318323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T11:44:34Z","timestamp":1637754274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915318323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0022354915318323"],"URL":"https:\/\/doi.org\/10.1002\/jps.22649","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}